December 20, 2010

Drugs for bacterial infections and cancer, and one that could help shape regulations for biosimilars, are featured in the Food and Drug Administration’s annual "Generic Drug Roundup."

December 15, 2010

Novartis on Wednesday announced that its merger agreement with Alcon has been settled to the tune of $12.9 billion. The new $8.7 billion Alcon eye care division, which includes CIBA Vision and selected ophthalmic medicines, will be led by current Alcon president and CEO Kevin Buehler.

December 7, 2010

NEW YORK — Last year, the big question on every­one’s mind was: How many brands can actually thrive in what has become a cluttered antacid shelf? Because just exactly how many heartburn sufferers are there?


November 17, 2010

Swiss drug maker Novartis will focus on innovation as part of a program for long-term...

November 14, 2010

William Gibson, the science-fiction author who helped create the cyberpunk genre in the 1980s and...

November 14, 2010

K-V Pharmaceutical has created a new marketing subsidiary for generic drugs, the company said. K-V...

November 8, 2010

Government officials said problems have arisen with the Food and Drug Administration’s approval of a...

October 31, 2010

The Food and Drug Administration has approved a cancer drug for treating tumors associated with...

October 27, 2010

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

October 25, 2010

An investigative vaccine made by Novartis appears to offer good protection against meningococcal disease in...

October 21, 2010

Drug maker Hospira has launched a generic treatment for bacterial infections, Hospira said Thursday....

October 21, 2010

Sandoz has launched a generic antibiotic drug, the generics division of Swiss drug maker Novartis...

October 17, 2010

The Food and Drug Administration granted approval for Teva's abbreviated new drug application to market...

October 10, 2010

Humanity has come a long way since the days when people thought sickness came from...

October 4, 2010

Eye care company Alcon has appointed a new executive....

October 4, 2010

Human Genome Sciences and Novartis have decided not to further develop an investigative biologic treatment...

September 27, 2010

The market for hypertension drugs will drop by $3 billion by the end of the...

September 26, 2010

Biosimilars, biogenerics, follow-on biologics—whatever the designation one prefers for knockoffs of biotech drugs—they will soon...

September 23, 2010

Drug maker Warner Chilcott will buy the U.S. rights to a treatment for overactive bladder...

September 21, 2010

The Food and Drug Administration has approved a drug for reducing relapses in patients with...

September 21, 2010

Swiss drug maker Novartis said its investigational drug is the first to show promise in...

August 31, 2010

The charitable arm of the National Association of Chain Drug Stores received contributions from several...

August 29, 2010

Jeffrey Bailey has been appointed as King Pharmaceuticals' chief commercial officer, leading all sales, marketing,...

August 26, 2010

The Food and Drug Administration has approved a single-pill combination of two drugs made by...